Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Higher interleukin-6 levels and changes in transforming growth factor-ß are associated with lung impairment in pulmonary tuberculosis Source: ERJ Open Res, 7 (1) 00390-2020; 10.1183/23120541.00390-2020 Year: 2021
Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
Lung function, clinical status and serum/sputum IL-10 levels in CF patients Source: Eur Respir J 2006; 28: Suppl. 50, 484s Year: 2006
Extracorporal photosensitation in bleomycin-induced lung injury decreases IL-10 protein levels in BAL but not the level of inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005
Why does chronic bronchitis and lung infection accelerate lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021
Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009
Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPD Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011
Blood levels of TNF-α, IFN-γ, IL-10, TGF-β1 and lung functional parameters in patients with advanced and earlier lung sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Increased circulating fibrocytes associated with lung function decline in COPD patients with desaturation during 6 minute walk test Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients? Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
The relationship between lung function and BAL return in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Levels of IL-1β and TNFα production in patients with lung tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002
Comparison of serum IL-18 levels in tuberculosis with pneumonia, lung cancer and healthy controls Source: Eur Respir J 2003; 22: Suppl. 45, 340s Year: 2003
Association of airway bacterial load with serum CRP and fibrinogen in stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006
Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019